AHA 2005

Statins: It’s the LDL, Stupid!

In addition to lipid levels, statins are known to have anti-inflammatory, anti-thrombotic and immunomodulatory effects which could help explain their impact on cardiovascular outcomes. But do these pleiotropic effects matter, or is ta all down to lipid lowering? At the University of Iowa, Jennifer Robinson has been trying to find out.

Click here for all the interviews from AHA 2005

Similar Interviews

  • Meta-Analysis Proves Statins Help Patients With Diabetes
  • Colin Baigent REFERENCE: Lancet 371:117 January 11, 2008 COLIN BAIGENT, Oxford University

  • Statins and ARBs: a Special Combination?
  • John McMurray The VALIANT trial compared ACE-inhibitor, ARB and a combination of the two in high-risk post-MI patients, and found

  • Statins Protect Heart Patients from Sepsis
  • Donald Redelmeier, University of Toronto Abstract: Lancet 2006; 367:413 Treatment with the lipid lowering agents statins reduced the incidence of sepsis among

    Post a comment

    Subscribe to Audio Medica Podcast